{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-016326","form_type":"8-K","ticker":"FBIO","cik":"0001429260","company_name":"Fortress Biotech, Inc.","filed_at":"2023-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.044555+00:00","generated_at":"2026-06-10T02:11:17.768467+00:00","sec_items":["3.03","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Fortress Biotech (FBIO) effects 1-for-15 reverse stock split on Oct 10 to meet Nasdaq $1 bid","bullets":["Reverse split ratio of 1:15; shares reduce from ~134.1M to ~8.9M.","Effective at open on October 10, 2023; new CUSIP 34960Q307.","Stockholders approved split at Oct 9 special meeting: 92.4M for, 3.6M against, 1.0M abstain.","Purpose: comply with Nasdaq minimum $1.00 bid price continued listing requirement.","No fractional shares; cash payment in lieu; ticker FBIO unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-016326","json":"https://secwatch.observer/filing/0001558370-23-016326.json","markdown":"https://secwatch.observer/filing/0001558370-23-016326.md","text":"https://secwatch.observer/filing/0001558370-23-016326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429260/000155837023016326/0001558370-23-016326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429260/000155837023016326/fbio-20231009x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T02:11:17.768467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"868106d5ac59d4d02e8651de9a34be52b7f957f7","claim":"Fortress Biotech, Inc.: The Company filed a Certificate of Amendment to effect a 1-for-15 reverse stock split of common stock, approved by stockholders and board, effective October 10, 2023 (effective 2023-10-10).","evidence_excerpt":"On October 9, 2023, Fortress Biotech, Inc. (the “ Company ”) filed a Certificate of Amendment (the “ Amendment ”) to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of Delaware to effect a 1-for-15 reverse stock split (the “ Reverse Stock Split ”) of the Company’s shares of common stock, $0.001 par value (the “ Common Stock ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429260/000155837023016326/0001558370-23-016326-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-10-10"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}